Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst
In a report released on October 6, Thomas Smith from Leerink Partners reiterated a Buy rating on Abivax SA Sponsored ADR. The company’s shares closed yesterday at $87.01.Elevate Your Investing Strategy:...
Kepler Capital Sticks to Their Buy Rating for Abivax SA (0RA9)
Kepler Capital analyst Justine Telliez maintained a Buy rating on Abivax SA on October 6 and set a price target of €70.00. The company’s shares closed yesterday at €73.50.Elevate Your Investing Strategy:...
Why This French Biotech Stock Just Soared 586% in One Day
Shares of Abivax SA (NASDAQ: ABVX) went parabolic on Wednesday, skyrocketing 586% to close at $68.60 after the French biotech firm announced overwhelmingly positive Phase 3 data for its lead drug candidate,...